Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
PlainTrials
RecruitingNot a traditional drug phaseobservationalRules rewrite

Abdominal Symptoms and Rosacea: An Observational Study on the Association Between Irritable Bowel Syndrome …

To describe the prevalence of rosacea in a population of patients with IBS followed at a tertiary-level university medical center.

Official registry: https://clinicaltrials.gov/study/NCT07922668 · IRCCS Azienda Ospedaliero-Universitaria di Bologna · enrollment listed as 300

What this phase means

This is an observational study. You are not assigned a new experimental drug. Researchers measure what already happens in your care or in daily life.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

This listing is observational (StudyType). The registry does not assign a new experimental drug as the study intervention.

They plan to enroll about 300 people at Bologna. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

Sintomi Addominali e RosaceA: Studio Osservazionale Sull'Associazione Tra Sindrome Dell'Intestino Irritabile (IBS) e l'Asse Intestino-pelle

Primary outcome (registry wording): Percentage of patients diagnosed with rosacea among the patients diagnosed with IBS included in the study.

Who it is for (from inclusion criteria)

  • Ages 18 Years to any
  • Evaluation at the Internal Medicine, Digestive Physiopathology, and Dermatology outpatient clinics of the IRCCS AOU Policlinico di Sant'Orsola in Bologna within the last 12 months
  • Presence of a confirmed diagnosis of IBS and/or rosacea documented in the outpatient medical record
  • Availability of clinical data essential for the analysis

Public study contact (from the registry)

Giovanni Barbara, MD

0512144103

giovanni.barbara@unibo.it

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

1 listed

Related recruiting trials in this snapshot

FAQ about this NCT record

Is NCT07922668 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT07922668?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT07922668?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary